AAAAAA

   
Results: 1-25 | 26-42 |
Results: 26-42/42
SAFETY AND APPROPRIATE USE OF SALMETEROL IN THE TREATMENT OF ASTHMA
Authors: WELCH MJ SZEFLER SJ NELSON HS APTER AJ BRANDON ML CHERVINSKY P HANNAWAY PJ HENDELES L KATZ RM KEMP JP MELAMED J NICKLAS RA ROWE MS SIMONS E WOEHLER TR ZIERING WH
Citation: Mj. Welch et al., SAFETY AND APPROPRIATE USE OF SALMETEROL IN THE TREATMENT OF ASTHMA, Journal of allergy and clinical immunology, 98(3), 1996, pp. 475-480
EFFECTS OF MONTELUKAST (MK-0476), A NEW POTENT CYSTEINYL LEUKOTRIENE (LDT(4)) RECEPTOR ANTAGONIST, IN PATIENTS WITH CHRONIC ASTHMA
Authors: REISS TF ALTMAN LC CHERVINSKY P BEWTRA A STRICKER WE NOONAN GP KUNDU S ZHANG J
Citation: Tf. Reiss et al., EFFECTS OF MONTELUKAST (MK-0476), A NEW POTENT CYSTEINYL LEUKOTRIENE (LDT(4)) RECEPTOR ANTAGONIST, IN PATIENTS WITH CHRONIC ASTHMA, Journal of allergy and clinical immunology, 98(3), 1996, pp. 528-534
DOUBLE-STRENGTH BECLOMETHASONE DIPROPIONATE (84 MU-G SPRAY) AQUEOUS NASAL SPRAY IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS/
Authors: PRENNER BM CHERVINSKY P HAMPEL FC HOWLAND WC LAWRENCE M MELTZER EO MUNK ZM RATNER PH SELTZER JM SETTIPANE GA LORBER RR HARRISON JE
Citation: Bm. Prenner et al., DOUBLE-STRENGTH BECLOMETHASONE DIPROPIONATE (84 MU-G SPRAY) AQUEOUS NASAL SPRAY IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS/, Journal of allergy and clinical immunology, 98(2), 1996, pp. 302-308
INTRANASAL FLUTICASONE PROPIONATE (FP) IS MORE EFFECTIVE THAN LORATADINE (LOR) FOR TREATMENT OF SEASONAL ALLERGIC RHINITIS SYMPTOMS
Authors: NAYAK AS SHULAN D BERNSTEIN DI LIVEZEY M SETTIPANE G CHERVINSKY P MELAMED J SELCOW J REED KD ANSCHUETZ G COOK CK ROGENES PR
Citation: As. Nayak et al., INTRANASAL FLUTICASONE PROPIONATE (FP) IS MORE EFFECTIVE THAN LORATADINE (LOR) FOR TREATMENT OF SEASONAL ALLERGIC RHINITIS SYMPTOMS, Journal of allergy and clinical immunology, 97(1), 1996, pp. 63-63
LOW-DOSES OF INHALED FLUTICASONE PROPIONATE (FP) REDUCE BRONCHIAL HYPERRESPONSIVENESS (BHR)
Authors: NOONAN MJ MUNK ZM CHERVINSKY P DOCKHORN RJ PINNAS J WOLFE J CRESCENZI KL KELLERMAN DJ
Citation: Mj. Noonan et al., LOW-DOSES OF INHALED FLUTICASONE PROPIONATE (FP) REDUCE BRONCHIAL HYPERRESPONSIVENESS (BHR), Journal of allergy and clinical immunology, 97(1), 1996, pp. 273-273
SAFETY OF SALMETEROL IN THE MAINTENANCE TREATMENT OF ASTHMA
Authors: NATHAN RA SELTZER JM KEMP JP CHERVINSKY P ALEXANDER WJ LIDDLE R MILLS R
Citation: Ra. Nathan et al., SAFETY OF SALMETEROL IN THE MAINTENANCE TREATMENT OF ASTHMA, Annals of allergy, asthma, & immunology, 75(3), 1995, pp. 243-248
FLUTICASONE PROPIONATE REDUCES ORAL PREDNISONE USE WHILE IT IMPROVES ASTHMA CONTROL AND QUALITY-OF-LIFE
Authors: NOONAN M CHERVINSKY P BUSSE WW WEISBERG SC PINNAS J DEBOISBLANC BP BOLTANSKY H PEARLMAN D REPSHER L KELLERMAN D
Citation: M. Noonan et al., FLUTICASONE PROPIONATE REDUCES ORAL PREDNISONE USE WHILE IT IMPROVES ASTHMA CONTROL AND QUALITY-OF-LIFE, American journal of respiratory and critical care medicine, 152(5), 1995, pp. 1467-1473
DURATION OF ACTION OF A SINGLE-DOSE OF AZELASTINE IN PATIENTS WITH CHRONIC ASTHMA
Authors: CHERVINSKY P GROSSMAN J FREITAG JJ
Citation: P. Chervinsky et al., DURATION OF ACTION OF A SINGLE-DOSE OF AZELASTINE IN PATIENTS WITH CHRONIC ASTHMA, The Journal of asthma, 32(2), 1995, pp. 141-145
BETTER DRUG TRIALS - REPLY
Authors: CHERVINSKY P
Citation: P. Chervinsky, BETTER DRUG TRIALS - REPLY, Journal of allergy and clinical immunology, 96(4), 1995, pp. 568-568
DOUBLE STRENGTH BECLOMETHASONE DIPROPIONATE (84-MCG SPRAY) AQUEOUS NASAL SPRAY IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS (SAR)/
Authors: PRENNER B CHERVINSKY P HAMPEL FC HOWLAND WC LAWRENCE M MELTZER EO MUNK ZM RATNER PH SELTZER J SETTIPANE GA LORBER RL HARRISON JE
Citation: B. Prenner et al., DOUBLE STRENGTH BECLOMETHASONE DIPROPIONATE (84-MCG SPRAY) AQUEOUS NASAL SPRAY IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS (SAR)/, Journal of allergy and clinical immunology, 95(1), 1995, pp. 195-195
EFFICACY OF INHALED FLUTICASONE PROPIONATE (FP) IN ASTHMA OCCURS VIA TOPICAL RATHER THAN SYSTEMIC EFFECT
Authors: LAWRENCE M ZIERING W WOLFE J CHERVINSKY P WEBB DR WOODRING A HAMEDANI A KELLERMAN D SHAH T
Citation: M. Lawrence et al., EFFICACY OF INHALED FLUTICASONE PROPIONATE (FP) IN ASTHMA OCCURS VIA TOPICAL RATHER THAN SYSTEMIC EFFECT, Journal of allergy and clinical immunology, 95(1), 1995, pp. 311-311
INHALED FLUTICASONE PROPIONATE POWDER (FP) IN STEROID-NAIVE PATIENTS WITH ASTHMA
Authors: WASSERMAN SI MUNK ZM LAFORCE CF CHERVINSKY P HAMEDANI A KELLERMAN D SCHABERG A
Citation: Si. Wasserman et al., INHALED FLUTICASONE PROPIONATE POWDER (FP) IN STEROID-NAIVE PATIENTS WITH ASTHMA, Journal of allergy and clinical immunology, 95(1), 1995, pp. 312-312
FLUTICASONE PROPIONATE AEROSOL FOR THE TREATMENT OF ADULTS WITH MILD-TO-MODERATE ASTHMA
Authors: CHERVINSKY P VANAS A BRONSKY EA DOCKHORN R NOONAN M LAFORCE C PLESKOW W
Citation: P. Chervinsky et al., FLUTICASONE PROPIONATE AEROSOL FOR THE TREATMENT OF ADULTS WITH MILD-TO-MODERATE ASTHMA, Journal of allergy and clinical immunology, 94(4), 1994, pp. 676-683
FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY EFFECTIVELY TREATS PERENNIAL NONALLERGIC RHINITIS
Authors: SELNER J BANOV C BOLTANSKY H BRONSKY E CHERVINSKY P DRUCE H GEORGITIS J KAISER H LAFORCE C MELTZER E MUNK Z WEBB D FIELD E HAMEDANI A MILWEE S
Citation: J. Selner et al., FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY EFFECTIVELY TREATS PERENNIAL NONALLERGIC RHINITIS, Journal of allergy and clinical immunology, 93(1), 1994, pp. 165-165
SALMETEROL XINAFOATE FOR TREATMENT OF REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE IN CHILDREN
Authors: BISHOP AL CHERVINSKY P LIDDLE R BRANDI V
Citation: Al. Bishop et al., SALMETEROL XINAFOATE FOR TREATMENT OF REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE IN CHILDREN, Journal of allergy and clinical immunology, 93(1), 1994, pp. 248-248
ONCE-DAILY LORATADINE VERSUS ASTEMIZOLE ONCE-DAILY
Authors: CHERVINSKY P GEORGITIS J BANOV C BOGGS P STOUWE RV GREENSTEIN S
Citation: P. Chervinsky et al., ONCE-DAILY LORATADINE VERSUS ASTEMIZOLE ONCE-DAILY, Annals of allergy, 73(2), 1994, pp. 109-113
A COMPARISON OF TWICE-DAILY VERSUS 4 TIMES DAILY REGIMENS OF INHALED BECLOMETHASONE DIPROPIONATE (336 MCG DAY) IN STEROID RESPONSIVE ASTHMATICS/
Authors: PEARLMAN DS CHERVINSKY P LAFORCE CF SHARP JT MITCHELL R VANAS A
Citation: Ds. Pearlman et al., A COMPARISON OF TWICE-DAILY VERSUS 4 TIMES DAILY REGIMENS OF INHALED BECLOMETHASONE DIPROPIONATE (336 MCG DAY) IN STEROID RESPONSIVE ASTHMATICS/, The American review of respiratory disease, 147(4), 1993, pp. 289-289
Risultati: 1-25 | 26-42 |